Nanotherapeutic Approaches to Treat COVID-19-Induced Pulmonary Fibrosis

There have been significant collaborative efforts over the past three years to develop therapies against COVID-19. During this journey, there has also been a lot of focus on understanding at-risk groups of patients who either have pre-existing conditions or have developed concomitant health conditio...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanvinde, Shrey, Deodhar, Suyash, Kulkarni, Tanmay A., Jogdeo, Chinmay M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204512/
https://www.ncbi.nlm.nih.gov/pubmed/37218751
http://dx.doi.org/10.3390/biotech12020034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204512/
https://www.ncbi.nlm.nih.gov/pubmed/37218751
http://dx.doi.org/10.3390/biotech12020034

Ejemplares similares